Galderma Group AG Unsponsored ADR (GALDY)
Market Closed
10 Aug, 20:00
OTC PINK OTC PINK Primary 
XFRA $
43. 32
-1.59
-3.5297%
$
46.59B Market Cap
- P/E Ratio
0.38% Div Yield
16,391 Volume
- Eps
$ 44.91
Previous Close Want to track GALDY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
GALDY closed today lower at $43.32, a decrease of -3.5297% from yesterday's close, completing a monthly decrease of -0.5053% or -$0.22. Over the past 12 months, GALDY stock gained 5.9169%.
GALDY pays dividends to its shareholders, with the most recent payment made on May 12, 2026. The next estimated payment will be in 2 months ago on May 12, 2026 for a total of $0.06659.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
GALDY Chart
Galderma Group AG (GALDY) Q2 2026 Earnings Call Transcript
Galderma Group AG (GALDY) Q2 2026 Earnings Call Transcript
Seekingalpha | 2 weeks ago
Galderma Group AG (GALDY) Q1 2026 Sales/Trading Call Transcript
Galderma Group AG (GALDY) Q1 2026 Sales/Trading Call Transcript
Seekingalpha | 3 months ago
Galderma Group AG (GALDY) Q4 2025 Earnings Call Transcript
Galderma Group AG (GALDY) Q4 2025 Earnings Call Transcript
Seekingalpha | 5 months ago
Galderma Group AG Unsponsored ADR (GALDY) FAQ
What is the stock price today?
The current price is $43.32.
On which exchange is it traded?
Galderma Group AG Unsponsored ADR is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is GALDY.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.38%.
What is its market cap?
As of today, the market cap is 46.59B.
Has Galderma Group AG Unsponsored ADR ever had a stock split?
No, there has never been a stock split.
Galderma Group AG Unsponsored ADR Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Flemming Ornskov M.B.A., M.D., M.P.H. CEO | OTC PINK Exchange | 36321W105 CUSIP |
| US Country | 7,676 Employees | 12 May 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Galderma Group AG, established in 1981 and headquartered in Zug, Switzerland, stands as a preeminent global dermatology company. It maintains a commitment to serving the full spectrum of the dermatology field through a science-driven approach. Galderma offers a diverse portfolio that encompasses injectable aesthetics, dermatological skincare, and therapeutic dermatology, catering to a wide range of skincare needs. The company's global footprint underscores its dedication to advancing dermatological care and enhancing skin health for consumers worldwide.
Products and Services
Injectable Aesthetics:
- Dysport/Azzalure, Alluzience: These brands represent Galderma's contributions to the injectable aesthetics market, offering solutions for cosmetic improvements and anti-aging treatments.
- Restylane: A range of hyaluronic acid fillers designed for various cosmetic enhancements, including facial wrinkles and folds, lip augmentation, and contouring.
- Sculptra: A poly-L-lactic acid-based injectable that stimulates collagen production, designed for the restoration and/or correction of the signs of facial fat loss.
Dermatological Skincare:
- Cetaphil: A dermatologically tested skincare line that includes cleansers, moisturizers, and baby products, recognized for its gentle and effective formula suitable for almost all skin types.
- Alastin: A scientifically formulated, clinically tested skincare range designed to enhance procedure outcomes and daily skincare routines with cutting-edge technology.
Therapeutic Dermatology:
- Soolantra, Epiduo, Differin: Topical treatments targeting acne and rosacea, offering both prescription-strength and over-the-counter solutions.
- Aklief, Epsolay, Twyneo: The latest in Galderma's portfolio, providing innovative solutions for common skin concerns with a focus on acne and rosacea treatments.
- Oracea, Metvix: Oracea is used for treating rosacea, while Metvix offers a photodynamic therapy solution for certain skin conditions.
- Benzac: A line of over-the-counter acne solutions that utilizes benzoyl peroxide to fight acne-causing bacteria and exfoliate the skin.
- Loceryl: An antifungal nail lacquer used for the treatment of fungal nail infections, providing a localized and targeted approach.
Contact Information
Address: Zählerweg 10, Zug, Switzerland, 6300
Phone: 41 58 455 85 92
Website: https://www.galderma.com
